Teresa Nunes is the Chief Medical Officer at CATO SMS responsible for controlling and monitoring the activities of the medical affairs and pharmacovigilance teams. Dr. Nunes also provides clients with strategic support in trial design and study execution for programs focusing on rare diseases, gene therapies, pediatrics, oncology, dermatology, and central nervous system.
Before joining CATO SMS, Dr. Nunes served as vice president and global head of medical affairs at Premier Research, where she led the medical, pharmacovigilance, and pharmacokinetic departments. She has also held various medical roles at Vertex Pharmaceuticals, BlueClinical, PRA Health Sciences, and Bial. Overall, Dr. Nunes has contributed directly to the design and medical and safety oversight of over 100 Phase I-IV studies in various therapeutic areas, some of which have led to market authorization in Europe and the United States.
Dr. Nunes holds an MD from the University of Coimbra in Portugal, an MSc in Clinical Pharmacology from the University of Surrey in the UK, and an MBA from the Fernando Pessoa University in Portugal. Dr. Nunes is also board certified in clinical pharmacology, with an active license to practice in the UK and Portugal.